Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 6/20 | 0.64 |
| ▸ | SELP | P16109 | 2/20 | 0.57 |
| ▸ | SELL | P14151 | 1/20 | 0.57 |
| ▸ | SELE | P16581 | 5/20 | 0.56 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16273961 | 1.00 | MAG (0.64) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL11940303 | 0.92 | MAG (0.62) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL12920101 | 0.90 | MAG (0.63) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL16273967 | 0.90 | MAG (0.61) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL12919644 | 0.90 | MAG (0.61) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL11940333 | 0.90 | MAG (0.61) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL25124354 | 0.89 | SELP (0.70) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL27420909 | 0.89 | SELP (0.70) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL15958765 | 0.87 | SIGLEC7 (0.70) | MAGSELPSELLSELESIGLEC7 | |
| SCHEMBL15958767 | 0.87 | SIGLEC7 (0.70) | MAGSELPSELLSELESIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9259476-B2 | Monophosphorylated lipid A derivatives | WAYNE STATE UNIVERSITY (US) | 2016-02-16 | — | — | US | disclosed |
| US-20140356367-A1 | MONOPHOSPHORYLATED LIPID A DERIVATIVES | WAYNE STATE UNIVERSITY | 2014-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140356367-A1 | MONOPHOSPHORYLATED LIPID A DERIVATIVES | SGMS1, PCYT1A, PHOSPHO1 | MAG 758/4885SELP 1038/4885SELL 2108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.